Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Idioma: Inglés
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 42,94
Convertir monedaCantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Idioma: Inglés
Librería: California Books, Miami, FL, Estados Unidos de America
EUR 46,20
Convertir monedaCantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Idioma: Inglés
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 62,84
Convertir monedaCantidad disponible: 4 disponibles
Añadir al carritoCondición: New.
Publicado por LAP Lambert Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Idioma: Inglés
Librería: AussieBookSeller, Truganina, VIC, Australia
EUR 44,83
Convertir monedaCantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. Hypertension is a prevalent condition, especially in those over 50, and can lead to severe cardiovascular complications. Irbesartan, an angiotensin II receptor blocker (ARB), is commonly used to manage hypertension, but its low aqueous solubility (1 mg/ml) limits its bioavailability. This study aimed to improve Irbesartan's solubility through solid dispersions using carriers like b-cyclodextrin, HPMC K4M, PEG4000, and Gelatin. b-cyclodextrin showed the greatest enhancement in solubility, as confirmed by phase solubility studies. Characterization through DSC and SEM indicated the drug's transformation from crystalline to amorphous form, improving dissolution. FTIR studies confirmed no interaction between the drug and carriers. In vitro dissolution tests revealed that b-cyclodextrin (1:9) formulations significantly increased the dissolution rate compared to pure Irbesartan and other carriers. Thus, using b-cyclodextrin in solid dispersions effectively enhances Irbesartan's solubility and therapeutic potential in treating hypertension. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Publicado por LAP LAMBERT Academic Publishing Sep 2024, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Idioma: Inglés
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 43,90
Convertir monedaCantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Neuware -Hypertension is a prevalent condition, especially in those over 50, and can lead to severe cardiovascular complications. Irbesartan, an angiotensin II receptor blocker (ARB), is commonly used to manage hypertension, but its low aqueous solubility (1 ¿g/ml) limits its bioavailability. This study aimed to improve Irbesartan¿s solubility through solid dispersions using carriers like ¿-cyclodextrin, HPMC K4M, PEG4000, and Gelatin. ¿-cyclodextrin showed the greatest enhancement in solubility, as confirmed by phase solubility studies. Characterization through DSC and SEM indicated the drug¿s transformation from crystalline to amorphous form, improving dissolution. FTIR studies confirmed no interaction between the drug and carriers. In vitro dissolution tests revealed that ¿-cyclodextrin (1:9) formulations significantly increased the dissolution rate compared to pure Irbesartan and other carriers. Thus, using ¿-cyclodextrin in solid dispersions effectively enhances Irbesartan¿s solubility and therapeutic potential in treating hypertension.Books on Demand GmbH, Überseering 33, 22297 Hamburg 84 pp. Englisch.
Publicado por LAP Lambert Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Idioma: Inglés
Librería: CitiRetail, Stevenage, Reino Unido
EUR 48,35
Convertir monedaCantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. Hypertension is a prevalent condition, especially in those over 50, and can lead to severe cardiovascular complications. Irbesartan, an angiotensin II receptor blocker (ARB), is commonly used to manage hypertension, but its low aqueous solubility (1 mg/ml) limits its bioavailability. This study aimed to improve Irbesartan's solubility through solid dispersions using carriers like b-cyclodextrin, HPMC K4M, PEG4000, and Gelatin. b-cyclodextrin showed the greatest enhancement in solubility, as confirmed by phase solubility studies. Characterization through DSC and SEM indicated the drug's transformation from crystalline to amorphous form, improving dissolution. FTIR studies confirmed no interaction between the drug and carriers. In vitro dissolution tests revealed that b-cyclodextrin (1:9) formulations significantly increased the dissolution rate compared to pure Irbesartan and other carriers. Thus, using b-cyclodextrin in solid dispersions effectively enhances Irbesartan's solubility and therapeutic potential in treating hypertension. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Publicado por LAP Lambert Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Idioma: Inglés
Librería: Grand Eagle Retail, Mason, OH, Estados Unidos de America
EUR 46,20
Convertir monedaCantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. Hypertension is a prevalent condition, especially in those over 50, and can lead to severe cardiovascular complications. Irbesartan, an angiotensin II receptor blocker (ARB), is commonly used to manage hypertension, but its low aqueous solubility (1 mg/ml) limits its bioavailability. This study aimed to improve Irbesartan's solubility through solid dispersions using carriers like b-cyclodextrin, HPMC K4M, PEG4000, and Gelatin. b-cyclodextrin showed the greatest enhancement in solubility, as confirmed by phase solubility studies. Characterization through DSC and SEM indicated the drug's transformation from crystalline to amorphous form, improving dissolution. FTIR studies confirmed no interaction between the drug and carriers. In vitro dissolution tests revealed that b-cyclodextrin (1:9) formulations significantly increased the dissolution rate compared to pure Irbesartan and other carriers. Thus, using b-cyclodextrin in solid dispersions effectively enhances Irbesartan's solubility and therapeutic potential in treating hypertension. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Publicado por LAP LAMBERT Academic Publishing Sep 2024, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Idioma: Inglés
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 43,90
Convertir monedaCantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 84 pp. Englisch.
Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Idioma: Inglés
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 44,59
Convertir monedaCantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Hypertension is a prevalent condition, especially in those over 50, and can lead to severe cardiovascular complications. Irbesartan, an angiotensin II receptor blocker (ARB), is commonly used to manage hypertension, but its low aqueous solubility (1 ¿g/ml) limits its bioavailability. This study aimed to improve Irbesartan¿s solubility through solid dispersions using carriers like ¿-cyclodextrin, HPMC K4M, PEG4000, and Gelatin. ¿-cyclodextrin showed the greatest enhancement in solubility, as confirmed by phase solubility studies. Characterization through DSC and SEM indicated the drug¿s transformation from crystalline to amorphous form, improving dissolution. FTIR studies confirmed no interaction between the drug and carriers. In vitro dissolution tests revealed that ¿-cyclodextrin (1:9) formulations significantly increased the dissolution rate compared to pure Irbesartan and other carriers. Thus, using ¿-cyclodextrin in solid dispersions effectively enhances Irbesartan¿s solubility and therapeutic potential in treating hypertension.
Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Idioma: Inglés
Librería: Majestic Books, Hounslow, Reino Unido
EUR 64,90
Convertir monedaCantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand.
Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Idioma: Inglés
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 66,89
Convertir monedaCantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND.